Immunotherapy with rituximab/interleukin 2 (IL-2) following autologous peripheral blood stem cell transplant (ASCT) as treatment for CD20 positive non-hodgkin’s lymphoma
2006 ◽
Vol 12
(2)
◽
pp. 116
2004 ◽
Vol 22
(14_suppl)
◽
pp. 6534-6534
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 6534-6534
2009 ◽
Vol 15
(2)
◽
pp. 39
1999 ◽
Vol 24
(12)
◽
pp. 1351-1354
◽
1998 ◽
Vol 100
(2)
◽
pp. 348-350
◽
2000 ◽
Vol 110
(3)
◽
pp. 631-637
◽
1999 ◽
Vol 105
(2)
◽
pp. 349-360
◽
2004 ◽
Vol 33
(7)
◽
pp. 703-707
◽